US20030215798A1
(en)
*
|
1997-06-16 |
2003-11-20 |
Diversa Corporation |
High throughput fluorescence-based screening for novel enzymes
|
US5880972A
(en)
*
|
1996-02-26 |
1999-03-09 |
Pharmacopeia, Inc. |
Method and apparatus for generating and representing combinatorial chemistry libraries
|
US20030054543A1
(en)
*
|
1997-06-16 |
2003-03-20 |
Lafferty William Michael |
Device for moving a selected station of a holding plate to a predetermined location for interaction with a probe
|
US20040241759A1
(en)
*
|
1997-06-16 |
2004-12-02 |
Eileen Tozer |
High throughput screening of libraries
|
US20020102598A1
(en)
*
|
1997-06-16 |
2002-08-01 |
Lafferty William Michael |
Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe
|
US20050070005A1
(en)
*
|
1997-06-16 |
2005-03-31 |
Martin Keller |
High throughput or capillary-based screening for a bioactivity or biomolecule
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
WO2000031536A2
(en)
*
|
1998-11-23 |
2000-06-02 |
President And Fellows Of Harvard College |
Detecting structural or synthetic information about chemical compounds
|
US6254835B1
(en)
*
|
1999-03-31 |
2001-07-03 |
Pharmacopeia, Inc. |
Methods and apparatus for improved fluid control utilizing a u-valve employing a bidirectional check valve
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
AU5077401A
(en)
|
2000-02-08 |
2001-08-20 |
Sangamo Biosciences Inc |
Cells for drug discovery
|
US7923542B2
(en)
|
2000-04-28 |
2011-04-12 |
Sangamo Biosciences, Inc. |
Libraries of regulatory sequences, methods of making and using same
|
AU2001257331A1
(en)
|
2000-04-28 |
2001-11-12 |
Sangamo Biosciences, Inc. |
Methods for designing exogenous regulatory molecules
|
ATE374249T1
(de)
|
2000-04-28 |
2007-10-15 |
Sangamo Biosciences Inc |
Datenbanken von regulatorischen sequenzen, methoden zu ihrer herstellung und verwendung
|
WO2001084148A2
(en)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
|
GB2365969A
(en)
|
2000-04-28 |
2002-02-27 |
Sangamo Biosciences Inc |
Methods for binding an exogenous molecule to cellular chromatin
|
DE60136272D1
(de)
|
2000-04-29 |
2008-12-04 |
Univ Iowa Res Found |
Diagnostika und therapeutika für makula degeneration erkrankungen
|
WO2002030465A2
(en)
|
2000-10-12 |
2002-04-18 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
US7378280B2
(en)
|
2000-11-16 |
2008-05-27 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
MXPA03006344A
(es)
*
|
2001-01-19 |
2004-12-03 |
Egea Biosciences Inc |
Montaje dirigido por computadora de un polinucleotido que codifica un polipeptido objetivo.
|
JP4342934B2
(ja)
|
2001-06-11 |
2009-10-14 |
キセノポート インコーポレーティッド |
Pept−2輸送体を介した薬剤の投与
|
WO2002102820A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
DE10147074A1
(de)
*
|
2001-09-25 |
2003-05-08 |
Beru Ag |
Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
|
EP1572168B1
(de)
|
2002-02-06 |
2010-05-26 |
Vicor Technologies, Inc. |
Anti-infarkt-moleküle
|
ATE414769T1
(de)
|
2002-03-15 |
2008-12-15 |
Nuevolution As |
Eine verbesserte methode zur synthese von matritzenabhängigen molekülen
|
WO2004013070A2
(en)
*
|
2002-08-01 |
2004-02-12 |
Nuevolution A/S |
Multi-step synthesis of templated molecules
|
EP2116604A1
(de)
|
2002-08-05 |
2009-11-11 |
University of Rochester |
Proteinumwandlungsdomäne / Deaminasechimäre Proteine, zugehörige Verbindungen und Verwendungen davon
|
LT2348125T
(lt)
|
2002-10-30 |
2017-09-11 |
Nuevolution A/S |
Bifunkcinio komplekso sintezės būdas
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
KR100915257B1
(ko)
|
2002-11-27 |
2009-09-03 |
아이알엠 엘엘씨 |
단일클론 항-dr5 효능제 항체, 그 항체를 발현하는 단리된 세포, 그 항체를 포함하는 제약 조성물 및 그 항체를 사용하는 방법
|
ATE450609T1
(de)
*
|
2002-12-19 |
2009-12-15 |
Nuevolution As |
Durch quasizufallsstrukturen und funktionen geführte synthesemethode
|
BRPI0407058A
(pt)
|
2003-02-01 |
2006-01-17 |
Neuralab Ltd |
Métodos de profilaxia e de tratamento de uma doença, composição farmacêutica, e, uso de um fragmento
|
WO2004074429A2
(en)
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
Method for producing second-generation library
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
HUE034320T2
(en)
|
2003-05-19 |
2018-02-28 |
Prothena Biosciences Ltd |
Truncated fragments of alpha-synuclein in lewy-body disease
|
US8153410B2
(en)
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
US20060162014A1
(en)
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
US11118215B2
(en)
*
|
2003-09-18 |
2021-09-14 |
Nuevolution A/S |
Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
|
JP4696079B2
(ja)
|
2003-12-17 |
2011-06-08 |
ヤンセン アルツハイマー イミュノセラピー |
Aβ免疫原性ペプチド担体結合物およびそれの製造方法
|
SG149013A1
(en)
|
2003-12-17 |
2009-01-29 |
Wyeth Corp |
Immunogenic peptide carrier conjugates and methods of producing same
|
EP1723255B1
(de)
*
|
2004-02-17 |
2010-12-29 |
Nuevolution A/S |
Anreicherungsverfahren mit eliminierung durch fehlpaarungshybridisierung
|
US7572600B2
(en)
|
2004-08-04 |
2009-08-11 |
Chemocentryx, Inc. |
Enzymatic activities in chemokine-mediated inflammation
|
EA013752B1
(ru)
|
2004-08-09 |
2010-06-30 |
Элан Фармасьютикалз, Инк. |
Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
|
WO2006018277A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Universität Bern |
Method for rational combinatorial synthesis
|
US7745389B2
(en)
|
2005-02-14 |
2010-06-29 |
University Of Iowa Research Foundation |
Methods for treatment of age-related macular degeneration
|
EP1874950B1
(de)
|
2005-04-05 |
2015-06-03 |
Corning Incorporated |
Markierungsfreie biosensoren
|
EP2371843B1
(de)
|
2005-05-19 |
2014-09-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
Funktionelle Epitope des Pneumokokken-Antigens und deren Nutzung
|
US8193328B2
(en)
|
2005-09-08 |
2012-06-05 |
Philadelphia Health & Education Corporation |
Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
AU2006304321B2
(en)
|
2005-10-14 |
2012-10-04 |
Musc Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
DK2341140T3
(da)
|
2005-12-01 |
2017-11-06 |
Nuevolution As |
Fremgangsmåde til enzymatisk kodning ved effektiv syntese af store biblioteker
|
WO2008042024A2
(en)
|
2006-06-01 |
2008-04-10 |
Elan Pharmaceuticals, Inc. |
Neuroactive fragments of app
|
EP2560001B1
(de)
|
2006-09-21 |
2016-04-13 |
University of Rochester |
Zusammensetzungen und Verfahren für eine Proteinverlagerungstherapie für myotone Dystrophie
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
EP2117575A4
(de)
|
2007-01-03 |
2013-06-05 |
Burnham Inst Medical Research |
Verfahren und zusammensetzungen in verbindung mit gerinnselbindenden verbindungen
|
CA2677665C
(en)
|
2007-02-08 |
2019-11-05 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
PL2118300T3
(pl)
|
2007-02-23 |
2015-11-30 |
Prothena Biosciences Ltd |
Zapobieganie i leczenie synukleinopatii i amyloidozy
|
PL3067066T3
(pl)
|
2007-02-23 |
2019-09-30 |
Prothena Biosciences Limited |
Zapobieganie i leczenie choroby synukleinopatycznej i amyloidogennej
|
US8779088B2
(en)
|
2007-12-17 |
2014-07-15 |
Marfl Ab |
Vaccine for the treatment of Mycobacterium related disorders
|
PT2237803E
(pt)
|
2007-12-28 |
2015-10-16 |
Prothena Biosciences Ltd |
Tratamento e profilaxia da amiloidose
|
WO2009091586A2
(en)
|
2008-01-18 |
2009-07-23 |
North Carolina State University |
Peptides and methods of use as therapeutics and screening agents
|
WO2010019963A2
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
EP2334791B1
(de)
|
2008-08-18 |
2016-07-13 |
Medicinal Bioconvergence Research Center |
Verfahren zur kontrolle der tumormetastasierung oder tumorzellwanderung durch modulation der zellulären lysyl-trna-synthetase-konzentration
|
EP2370080A1
(de)
|
2008-12-02 |
2011-10-05 |
University of Utah Research Foundation |
Pde1 als zieltherapeutikum bei herzkrankheiten
|
AU2009322346B2
(en)
|
2008-12-03 |
2015-07-02 |
The Scripps Research Institute |
Stem cell cultures
|
EP2443459B1
(de)
|
2009-06-19 |
2018-12-26 |
The Arizona Board of Regents, A Body Corporate Of the State of Arizona acting for and on behalf Of Arizona State University |
Verbindungsanordnungen für probenprofil
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
US20110081293A1
(en)
|
2009-10-07 |
2011-04-07 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
JP2013515008A
(ja)
|
2009-12-18 |
2013-05-02 |
サンフォード−バーナム メディカル リサーチ インスティテュート |
凝血塊結合化合物に関連する方法および組成物
|
SI2558577T1
(sl)
|
2010-04-16 |
2019-05-31 |
Nuevolution A/S |
Bifunkcionalni kompleksi in metode za pripravo in uporabo takšnih kompleksov
|
EP2691105B1
(de)
|
2011-03-28 |
2018-07-11 |
University of Utah Research Foundation |
Verfahren und zusammensetzungen zur viruseindringungshemmung
|
EP2714921A4
(de)
|
2011-05-26 |
2015-05-13 |
Univ Michigan |
Epigenetische corepressoren des gamma-globin-gens und verwendungsverfahren dafür
|
WO2013043012A2
(en)
|
2011-09-22 |
2013-03-28 |
Medicinal Bioconvergence Research Center |
Novel use of leucyl trna synthetase
|
EP2748307A4
(de)
|
2011-09-23 |
2015-08-19 |
Univ Louisville Res Found |
Verfahren und zusammensetzungen zur expansion von zellen und verbesserten transplantation
|
KR101398079B1
(ko)
|
2011-10-10 |
2014-05-27 |
재단법인 의약바이오컨버젼스연구단 |
글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법
|
WO2013078138A1
(en)
|
2011-11-21 |
2013-05-30 |
OSI Pharmaceuticals, LLC |
Proton nmr spectroscopy for biochemical screening
|
US9970932B2
(en)
|
2013-03-15 |
2018-05-15 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Non-covalent patterned chemical features and use thereof in MALDI-based quality control
|
WO2014145123A2
(en)
|
2013-03-15 |
2014-09-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State Unversity |
Peptide array quality control
|
US11142577B2
(en)
|
2014-09-12 |
2021-10-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
WNT signaling agonist molecules
|
WO2016100857A1
(en)
|
2014-12-19 |
2016-06-23 |
Regeneron Pharmaceuticals, Inc. |
Stem cells for modeling type 2 diabetes
|
CN108474795B
(zh)
|
2015-04-20 |
2021-10-29 |
豪夫迈·罗氏有限公司 |
经由系统发现、成熟和延伸过程鉴定的针对蛋白质的特异性肽结合剂
|
US10758886B2
(en)
|
2015-09-14 |
2020-09-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Conditioned surfaces for in situ molecular array synthesis
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
WO2017223116A2
(en)
|
2016-06-20 |
2017-12-28 |
Healthtell Inc. |
Methods for differential diagnosis of autoimmune diseases
|
CA3028975A1
(en)
|
2016-06-20 |
2017-12-28 |
Healthtell Inc. |
Methods for diagnosis and treatment of autoimmune diseases
|
HUE055402T2
(hu)
|
2016-07-06 |
2021-11-29 |
Prothena Biosciences Ltd |
Esszé összes és S129 foszforilezett alfa-szinuklein kimutatására
|
WO2018023014A1
(en)
|
2016-07-29 |
2018-02-01 |
Regeneron Pharmaceuticals, Inc. |
Mice comprising mutations resulting in expression of c-truncated fibrillin-1
|
EP3526346A1
(de)
|
2016-10-12 |
2019-08-21 |
Janssen Biotech, Inc. |
Verfahren zum screening auf modulatoren der gdf15-artigen biologischen aktivität
|
WO2018089858A1
(en)
|
2016-11-11 |
2018-05-17 |
Healthtell Inc. |
Methods for identifying candidate biomarkers
|
WO2018202850A1
(en)
|
2017-05-05 |
2018-11-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
|
US20200209241A1
(en)
|
2017-09-15 |
2020-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
ES2911249T3
(es)
|
2017-11-10 |
2022-05-18 |
Regeneron Pharma |
Animales no humanos que comprenden una mutación de slc30a8 y métodos de uso
|
US20210396761A1
(en)
|
2018-07-20 |
2021-12-23 |
Aicuris Gmbh & Co. Kg |
Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses
|
JP2022526429A
(ja)
|
2019-04-10 |
2022-05-24 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
Amdの処置のためのhtra1調節
|
WO2021067550A1
(en)
|
2019-10-02 |
2021-04-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|